Nowadays, the median overall survival of molecular defined oligodendrogliomas, IDH-mutant and 1p/19q codeleted can be estimated to be in the range of 15–20 years, if treated with radiochemotherapy [10, 43]. Here, IDH1 is linked to oligodendroglioma.